SCHEMBL23970968

SCHEMBL23970968

COC(=O)c1cc2cc(F)c(Cl)nc2n1S(=O)(=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD2 Q9HC29 4/20 0.42
NOD1 Q9Y239 4/20 0.42
HDAC3 O15379 3/20 0.38
HDAC4 P56524 3/20 0.38
HDAC1 Q13547 3/20 0.38
HDAC7 Q8WUI4 3/20 0.38
HDAC2 Q92769 3/20 0.38
HDAC10 Q969S8 3/20 0.38
HDAC11 Q96DB2 3/20 0.38
HDAC8 Q9BY41 3/20 0.38
HDAC6 Q9UBN7 3/20 0.38
HDAC9 Q9UKV0 3/20 0.38
HDAC5 Q9UQL6 3/20 0.38
KMT2A Q03164 5/20 0.37
MEN1 O00255 2/20 0.37
LMNA P02545 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
CCR2 P41597 1/20 0.36
PTGDR2 Q9Y5Y4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30411438 0.86 NOD2 (0.41) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL24850176 0.86 NOD2 (0.41) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL29187884 0.84 NOD2 (0.40) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL30410427 0.84 NOD2 (0.40) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL24850174 0.77 NOD2 (0.37) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL2927020 0.76 PTGS2 (0.42) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL7745780 0.76 NOD2 (0.39) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL2924501 0.76 MAPT (0.42) NOD2NOD1HDAC3HDAC4HDAC1
SCHEMBL23148075 0.75 NOD1 (0.41) NOD2NOD1KMT2ALMNAALDH1A1
SCHEMBL9617940 0.74 NOD2 (0.64) NOD2NOD1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 CN disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 NOD2 1326/4885NOD1 2999/4885HDAC3 1138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.